Patents by Inventor Paramvir Bhadwal

Paramvir Bhadwal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10227317
    Abstract: Disclosed herein a process for the isolation of intermediate of Vortioxetine in a solid state form and an improved, commercially viable and industrially advantageous process for the preparation of vortioxetine or a pharmaceutically acceptable salt thereof, in high yield and purity.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: March 12, 2019
    Assignee: LUPIN LIMITED
    Inventors: Girij Pal Singh, Dhananjai Srivastava, Paramvir Bhadwal, Inamus Saqlain Ansari, Nilesh Shashikant Bhawsar
  • Patent number: 9981927
    Abstract: The present invention is directed to process for preparation of ?-form crystal of Mirabegron, (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino) ethyl) phenyl) acetamide of formula (1).
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: May 29, 2018
    Assignee: LUPIN LIMITED
    Inventors: Girij Pal Singh, Dhananjai Shrivastava, Paramvir Bhadwal, Malhari Deoram Bhor, Suryabhan Prabhakar Dange, Sonaraj Bholenath Jangam
  • Publication number: 20180030008
    Abstract: Disclosed herein a process for the isolation of intermediate of Vortioxetine in a solid state form and an improved, commercially viable and industrially advantageous process for the preparation of vortioxetine or a pharmaceutically acceptable salt thereof, in high yield and purity.
    Type: Application
    Filed: February 24, 2016
    Publication date: February 1, 2018
    Inventors: Girij Pal Singh, Dhananjai Srivastava, Paramvir Bhadwal, Inamus Saqlain Ansari, Nilesh Shashikant Bhawsar
  • Publication number: 20180016246
    Abstract: The present invention is directed to process for preparation of ?-form crystal of Mirabegron, (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl) amino) ethyl) phenyl) acetamide of formula (1).
    Type: Application
    Filed: February 2, 2016
    Publication date: January 18, 2018
    Inventors: Girij Pal Singh, Dhananjai Shrivastava, Paramvir Bhadwal, Malhari Deoram Bhor, Suryabhan Prabhakar Dange, Sonaraj Bholenath Jangam
  • Patent number: 7678927
    Abstract: The present invention relates to an improved and industrial friendly process for lactonization to produce compound of the Formula [I], from compound of the Formula [II] in presence of an inorganic compound as a suitable lactonizing agent, preferably alkali metal hydrogen sulfate, and crystallizing the obtained lactone product in a solvent; or treating compound of the Formula [II] in the presence of an inorganic compound preferably alkali metal hydrogen sulfate using phase transfer catalyst in heterogeneous phase followed by crystallizing the obtained lactone product in a solvent.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: March 16, 2010
    Assignee: Jubilant Organosys Limited
    Inventors: Govind Singh, Paramvir Bhadwal, Sanjay Jaiswal, Dinesh R. Panchasara, Rajesh Kumar Thaper, Sushil Kumar Dubey, Jag Mohan Khanna
  • Publication number: 20090099371
    Abstract: Disclosed is a novel process for preparing pure amorphous form of Atorvastatin employing a suitable solvent system selected from water, water-miscible solvents or water-immiscible solvents or a mixture thereof.
    Type: Application
    Filed: January 31, 2006
    Publication date: April 16, 2009
    Inventors: Runjhun Gupta, Khushi Ram, Paramvir Bhadwal, Rajesh Kumar Thaper, Sushil Kumar Dubeu
  • Publication number: 20070265457
    Abstract: The present invention relates to an improved and industrial friendly process for lactonization to produce compound of the Formula [I], from compound of the Formula [II] in presence of an inorganic compound as a suitable lactonizing agent, preferably alkali metal hydrogen sulfate, and crystallizing the obtained lactone product in a solvent; or treating compound of the Formula [II] in the presence of an inorganic compound preferably alkali metal hydrogen sulfate using phase transfer catalyst in heterogeneous phase followed by crystallizing the obtained lactone product in a solvent.
    Type: Application
    Filed: September 8, 2004
    Publication date: November 15, 2007
    Applicant: JUBILANT ORGANOSYS LIMITED
    Inventors: Govind Singh, Paramvir Bhadwal, Sanjay Jaiswal, Dinesh Panchasara, Rajesh Thaper, Sushil Dubey, Jag Khanna